Baihua Hu
0000-0002-1340-5811
Publication & Citation Trends
Publications
0 total
Discovery of TRPA1 Antagonist GDC-6599: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease. OA
Cited by 13
Semantic Scholar
Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1.
Cited by 8
Semantic Scholar
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1). OA
Cited by 36
Semantic Scholar
Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy.
Cited by 33
Semantic Scholar
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment OA
Cited by 106
Semantic Scholar
Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.
Cited by 29
Semantic Scholar
Research Topics
Receptor Mechanisms and Signaling
(6)
Cholesterol and Lipid Metabolism
(6)
Drug Transport and Resistance Mechanisms
(5)
Cyclopropane Reaction Mechanisms
(5)
Chemical Synthesis and Analysis
(4)
Affiliations
Eli Lilly (United States)
Pfizer (United States)
Princeton University
Pearl River Community College
South College